Influence of the Vibralung Acoustical Percussor on pulmonary function and sputum expectoration in individuals with cystic fibrosis
AuthorWheatley, Courtney M
Baker, Sarah E
Daines, Cori M
Martinez, Marina G
Morgan, Wayne J
Snyder, Eric M
AffiliationUniv Arizona, Dept Pharm Practice & Sci
Univ Arizona, Dept Pharm Practice & Sci
Univ Arizona, Dept Pediat Pediat Pulmonol & Sleep
Univ Arizona, USA Dept Pediat Pediat Pulmonol & Sleep
Univ Arizona, Arizona Clin Res Ctr
Keywordsairway clearance therapy
diffusing capacity of the lungs for carbon monoxide and nitric oxide
high-frequency chest wall oscillation/compression
oscillatory positive expiratory pressure
MetadataShow full item record
PublisherSAGE PUBLICATIONS LTD
CitationWheatley, C. M., Baker, S. E., Daines, C. M., Phan, H., Martinez, M. G., Morgan, W. J., & Snyder, E. M. (2018). Influence of the Vibralung Acoustical Percussor on pulmonary function and sputum expectoration in individuals with cystic fibrosis. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/1753466618770997
Rights© The Author(s), 2018.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractOver two separate studies, 10 and 11 mild to moderate CF patients were recruited for study I and II, respectively. Study I: Vibralung was used for 20 min with either no sound (NS: PEP only) or sound (S: PEP and sound) on randomized visits. Pulmonary function, diffusion capacity of the lungs for carbon monoxide and nitric oxide (DLCO/DLNO), symptoms, and peripheral oxygen saturation (SpO2) were measured at baseline and at 1 and 4 h post treatment. Expectorated sputum was collected over 4 h post treatment. Study II: over 5 days of in-hospital therapy, the Vibralung or vibratory vest therapy (Vest) were used for two therapy sessions per day, with sputum collected for 20 min following each therapy and pulmonary function accessed pre and post each 5-day period (days 1-5 or 7-11) in a randomized crossover design.
NoteOpen access journal
VersionFinal published version
SponsorsWestMed Inc., Tucson, AZ, USA
- Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial.
- Authors: Radtke T, Böni L, Bohnacker P, Maggi-Beba M, Fischer P, Kriemler S, Benden C, Dressel H
- Issue date: 2018 Jun 14
- Effect of high-frequency oral airway and chest wall oscillation and conventional chest physical therapy on expectoration in patients with stable cystic fibrosis.
- Authors: Scherer TA, Barandun J, Martinez E, Wanner A, Rubin EM
- Issue date: 1998 Apr
- Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial.
- Authors: San Miguel-Pagola M, Reychler G, Cebrià I Iranzo MA, Gómez-Romero M, Díaz-Gutiérrez F, Herrero-Cortina B
- Issue date: 2020 Jun
- Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis.
- Authors: van Winden CM, Visser A, Hop W, Sterk PJ, Beckers S, de Jongste JC
- Issue date: 1998 Jul
- Comparison of settings used for high-frequency chest-wall compression in cystic fibrosis.
- Authors: Kempainen RR, Milla C, Dunitz J, Savik K, Hazelwood A, Williams C, Rubin BK, Billings JL
- Issue date: 2010 Jun